IRCT2016040918858N3CompletedPhase 3
Effects of a 3 months treatment with selenium on serum Anti TPO level in patients with Hashimoto's thyroiditis compared with placebo
Yazd medical sciences University0 sites52 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 3
- Status
- Completed
- Sponsor
- Enrollment
- 52
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 15 years to 50 years (—)
- Sex
- All
Inclusion Criteria
- •Positivite Anti TPO; Age between 15-50 years;
- •Lack of kidney and liver disorder; lack of hyperthyroidism; not pregnancy;
- •Exclusion criteria: company dissatisfaction with the study; irregular drug use (no more than 20% of anticipated medications); patient's desire for each Time to leave the study
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Not yet recruiting
Phase 2
The effect of addition of selenium to treatment regimen of hospitalized patients with corona on the outcome of disease compared with control groupIRCT20160706028815N5Sabzevar University of Medical Sciences40
Recruiting
Phase 3
effect of selenium in systemic lupus erythematosusIRCT20210717051914N2Ahvaz University of Medical Sciences56
Recruiting
Not Applicable
Selenium and Coronary Artery Disease: Should we supplement high risk patients?Coronary Artery DiseaseCardiovascular - Other cardiovascular diseasesACTRN12605000412639Dr Nathalie van Havre400
Completed
Phase 3
Effect of selenium on malnutrition- inflamation complex syndrome (MICS) in hemodialysis patientsEnd stage renal disease , hemodialysis.Chronic renal failureIRCT138812043408N1Shiraz University of Medical Sciences80
Not yet recruiting
Phase 2
The effect of Selenium supplementation in high risk mothers for Preeclampsia screened with Quadruple testsPre-eclampsiaIRCT20200608047701N1Kashan University of Medical Sciences60